Neurent Medical
5 known investors
Neurent Medical develops the NEUROMARK System, a minimally invasive radiofrequency ablation device that disrupts overactive posterior nasal nerves to treat chronic rhinitis. It is used by ENT physicians to provide durable symptom relief for patients in the US.
Investors · 5
Funding
SEC filings, press & company announcements$135M disclosed across 2 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Neurent Medical do?
- Neurent Medical develops the NEUROMARK System, a minimally invasive radiofrequency ablation device that disrupts overactive posterior nasal nerves to treat chronic rhinitis. It is used by ENT physicians to provide durable symptom relief for patients in the US.
- Who are Neurent Medical's investors?
- Neurent Medical's investors include Atlantic Bridge Ventures, Enterprise Ireland, EQT Life Sciences, Fountain Healthcare Partners, Western Development Commission.
- How much funding has Neurent Medical raised?
- Neurent Medical has disclosed $135M raised across 2 rounds.
